Filing Details
- Accession Number:
- 0001415889-24-019306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-05 16:30:05
- Reporting Period:
- 2024-07-02
- Accepted Time:
- 2024-07-05 16:30:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-02 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-02 | 457 | $315.58 | 3,273 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-02 | 551 | $317.30 | 2,722 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-02 | 1,088 | $318.27 | 1,634 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-02 | 1,310 | $319.26 | 324 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-02 | 194 | $319.88 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-07-03 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-03 | 287 | $310.13 | 3,443 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-03 | 1,703 | $310.75 | 1,740 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-03 | 270 | $312.22 | 1,470 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-03 | 153 | $313.52 | 1,317 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-03 | 851 | $314.85 | 466 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-03 | 231 | $316.42 | 235 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-03 | 4 | $316.92 | 231 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-03 | 101 | $318.30 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-07-02 | 3,600 | $0.00 | 3,600 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-07-03 | 3,600 | $0.00 | 3,600 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 133,469 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 129,869 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 166 | Indirect | By Spouse |
| Common Stock | 245,909 | Indirect | By Trust |
| Common Stock | 2,706 | Indirect | By Trust |
| Common Stock | 28,170 | Indirect | By Trust |
| Common Stock | 324,518 | Indirect | By Trust |
| Common Stock | 45,596 | Indirect | By Trust |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $315.26 to $316.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $316.60 to $317.655. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $317.735 to $318.635. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $318.80 to $319.735. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $319.815 to $319.965. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $309.305 to $310.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $310.34 to $311.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $311.45 to $312.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $313.185 to $313.815. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $314.38 to $315.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $315.81 to $316.635. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $316.855 to $317.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $318.00 to $318.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person is sole trustee and members of the Reporting Person's immediate family are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Billionaire Hedge Funds
